FIELD: pharmaceuticals.
SUBSTANCE: pharmaceutical compositions comprising (a) at least one liposome with at least one vesicle-forming phospholipid; and (b) treprostinil encapsulated in a liposome are provided herein. The ratio of treprostinil and phospholipid equals or exceeds 0.035 and provides a controlled release of treprostinil.
EFFECT: use of pharmaceutical compositions for the treatment of respiratory diseases is also presented.
18 cl, 6 dwg, 7 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION FOR CONTROLLED RELEASE OF WEAK ACID DRUGS AND ITS USE | 2019 |
|
RU2810790C2 |
| LIPOSOMAL COMPOSITIONS CONTAINING SLIGHTLY ACIDIC DRUGS, AND THEIR USE | 2018 |
|
RU2778886C2 |
| LIPOSOMAL COMPOSITIONS USED FOR DRUG DELIVERY | 2015 |
|
RU2757110C2 |
| STABILIZED PHARMACEUTICAL COMPOSITIONS OF CAMPTOTHECIN | 2016 |
|
RU2732567C2 |
| LIPOSOMAL COMPOSITION AND METHOD OF OBTAINING THEREOF | 2011 |
|
RU2577683C2 |
| PROLONGED RELEASE OF ANTI-INFECTIOUS AGENTS | 2006 |
|
RU2438655C2 |
| LIPOSOMAL COMPOSITIONS APPLICABLE FOR DRUG DELIVERY | 2005 |
|
RU2574926C2 |
| IMPROVED LIPOSOMES AND THEIR APPLICATION | 2008 |
|
RU2482837C2 |
| LIPOSOMAL PHARMACEUTICAL PREPARATION AND METHOD FOR PREPARING IT | 2007 |
|
RU2494729C2 |
| LIPOSOMAL ANTITUMOR COMPOSITIONS | 2017 |
|
RU2756837C2 |
